Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
QuintilesIMS
Julphar
Queensland Health
UBS
Deloitte
Argus Health
Accenture
Cerilliant

Generated: January 17, 2019

DrugPatentWatch Database Preview

Drugs with Dosage: POWDER

« Back to Dashboard

Drugs with Dosage: POWDER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage
Lilly ALIMTA pemetrexed disodium POWDER;INTRAVENOUS 021462-002 Sep 7, 2007 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial POWDER;INTRAVENOUS
Teva Pharms CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 074555-001 Sep 30, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial POWDER;ORAL
Teva Pharms CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 074555-002 Sep 30, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial POWDER;ORAL
Gland Pharma Ltd CASPOFUNGIN ACETATE caspofungin acetate POWDER;INTRAVENOUS 207092-001 Sep 29, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial POWDER;INTRAVENOUS
Gland Pharma Ltd CASPOFUNGIN ACETATE caspofungin acetate POWDER;INTRAVENOUS 207092-002 Sep 29, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial POWDER;INTRAVENOUS
Mylan Labs Ltd CASPOFUNGIN ACETATE caspofungin acetate POWDER;INTRAVENOUS 207650-001 Sep 29, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial POWDER;INTRAVENOUS
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Moodys
McKinsey
Covington
Julphar
Cipla
Mallinckrodt
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.